Skip to content

A prospective study on the effect of biased µ receptor agonists on the postoperative rehabilitation quality of elderly patients with gastrointestinal tumors

A prospective study on the effect of biased µ receptor agonists on the postoperative rehabilitation quality of elderly patients with gastrointestinal tumors

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104081
Enrollment
Unknown
Registered
2025-06-10
Start date
2025-07-22
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tumor

Interventions

Experimental group:Thirty minutes before the end of the operation, Teligidine at a dose of 8 µg/kg was intravenously injected. At the end of the operation, an analgesic pump was connected: Teligidine
Control group:Thirty minutes before the end of the operation, sufentanil at a dose of 0.2 µg/kg was intravenously injected. After the operation, an analgesic pump was connected: sufentanil at a dose o

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age >=65 years old, <=85 years old, ASA grade II - III; 2. Laparoscopic gastric cancer surgery and/or laparoscopic colorectal cancer surgery are planned to be performed under general anesthesia; 3. The informed consent form can be signed; 4. Have the ability to read and write.

Exclusion criteria

Exclusion criteria: 1. Patients with severe respiratory depression, such as those with oxygen saturation below 90%, and those with acute or severe bronchial asthma; 2. Emergency surgery patients; 3. Those with severe dementia, language disorders, or severe hearing or vision impairment who are unable to complete the questionnaire survey; 4. Those who have severe heart, lung, liver or kidney dysfunction before the operation; 5. Those with a history of chronic pain and those who have been taking analgesic and sedative drugs for a long time; 6. Those with mental illness and cognitive dysfunction; 7. Known or suspected gastrointestinal obstruction, including patients with paralytic intestinal obstruction; 8. Patients who are allergic to opioid drugs or any of the components of this product.

Design outcomes

Primary

MeasureTime frame
The area under the cumulative curve (AUC) of the NRS score for pain at rest within 48 hours after surgery;

Secondary

MeasureTime frame
Postoperative pain scores at each time point;Number of PCA compressions;Anal exhaust time;Time of first eating;Diamine oxidase (DAO), D-lactic acid (D-LAC), Bacterial endotoxin (BE);The incidence of postoperative adverse reactions or complications (postoperative delirium, nausea, vomiting, pneumonia, transfer to ICU, hypoxia, intestinal obstruction) in patients;Postoperative rehabilitation quality;Length of hospital stay;

Countries

China

Contacts

Public ContactTianxiao Liu

The First Affiliated Hospital of Guangxi Medical University

liutxdoctor@qq.com+86 193 7883 5923

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026